Suppr超能文献

切尔诺贝利事故影响地区甲状腺癌伴第二原发非甲状腺恶性肿瘤的比较病理学特征。

Comparative pathological characteristics of papillary thyroid carcinoma with second primary non-thyroid malignancies in the region affected by the Chernobyl accident.

机构信息

Republican Centre for Thyroid Tumours, Department of Pathology, Nezavisimosty Av., 64, 220013 Minsk, Belarus.

United Institute of Informatics Problems, National Academy of Sciences of Belarus, Surganova St. 6, 220012 Minsk, Belarus.

出版信息

Pathol Res Pract. 2021 Dec;228:153658. doi: 10.1016/j.prp.2021.153658. Epub 2021 Oct 19.

Abstract

The aim was to study the pathological features of papillary thyroid carcinoma diagnosed with or before second primary malignancy in patients exposed to post-Chernobyl exposure. The patients selected (n = 6559) were those exposed to radiation at the age of ≤ 18 years old and developed papillary thyroid carcinoma during the years 1990-2020. Of these, 2.1% (n = 140) had second primary malignancies. To compare the histopathological characteristics of papillary thyroid carcinoma in the group under analysis, 91% (n = 128) with sufficient data were included in further analysis. The control group was formed by matching patients with age at exposure to radiation, age at surgery, gender, and place of residence. Median age at exposure was 14 years old for both groups. Besides, no difference in tumour extension and histological features of papillary thyroid carcinoma was noted between patients with synchronous or metachronous primary malignant tumours. Nevertheless, the time lag to the diagnosis of papillary thyroid carcinoma was shortened in the group with metachronous when compared to patients with synchronous second primaries (p < 0.001). Independent differences between patients with second primaries and their matched peers included tumour size {OR (95%CI) = 0.89 (0.45; 1.04)}, multiple tumours {OR (95% CI) = 1.46 (0.86; 2.42)}, lymphatic vessel invasion (OR (95%CI) 0.92 (0.61; 1.53)), blood vessel invasion (OR (95%CI) 0.41 (0.10; 1.23) and presence of numerous psammomas (OR (95%CI) 0.73 (0.39; 1.31)). The possible influence of radiative iodine treatment for development of second primaries was analysed for the group of patients with metachronous malignancies using the same approach (84 patients were compared to 252 matched patients). Independent differences also included tumour size {OR (95% CI) 0.77 (0.45; 1.30)}, lymphatic vessel invasion {OR (95%CI) 0.75(0.43; 1.28)}, blood vessel invasion {OR (95%CI) 0.17 (0.01; 0.87)}. Besides, multiple tumours were revealed more frequently in patients with metachronous primaries (OR (95%CI) 1.92 (1.0; 3.62)). To conclude, patients exposed to Chernobyl irradiation with the development of papillary thyroid carcinoma and second primary malignancy have less biological aggressive pathological characteristics of their thyroid cancers. Accordingly, these patients were less frequently treated with post-surgical radioactive iodine. Thus, 131I-irradiation may have negligible impact on the development of second primaries.

摘要

目的是研究切尔诺贝利事故后暴露于辐射的患者中诊断为或在第二原发性恶性肿瘤之前诊断为甲状腺乳头状癌的患者的病理特征。选择的患者(n=6559)为在≤18 岁时接受辐射,并且在 1990-2020 年期间患有甲状腺乳头状癌。其中,2.1%(n=140)患有第二原发性恶性肿瘤。为了比较分析组中甲状腺乳头状癌的组织病理学特征,将 91%(n=128)具有足够数据的患者纳入进一步分析。对照组通过匹配暴露于辐射时的年龄、手术时的年龄、性别和居住地来形成。两组的中位暴露年龄均为 14 岁。此外,在同步或异时性原发性恶性肿瘤患者中,未观察到甲状腺乳头状癌的肿瘤扩展和组织学特征存在差异。然而,与同步发生第二原发性肿瘤的患者相比,异时性发生第二原发性肿瘤的患者的甲状腺乳头状癌诊断时间间隔缩短(p<0.001)。与第二原发性肿瘤患者及其匹配的同龄人之间存在独立差异,包括肿瘤大小[比值比(95%CI)=0.89(0.45;1.04)]、多个肿瘤[比值比(95%CI)=1.46(0.86;2.42)]、淋巴管浸润(比值比(95%CI)0.92(0.61;1.53))、血管浸润(比值比(95%CI)0.41(0.10;1.23)和存在大量沙粒体(比值比(95%CI)0.73(0.39;1.31))。对于异时性恶性肿瘤的患者组,使用相同的方法分析了放射性碘治疗对第二原发性肿瘤发展的可能影响(将 84 例患者与 252 例匹配患者进行比较)。独立差异还包括肿瘤大小[比值比(95%CI)0.77(0.45;1.30)]、淋巴管浸润[比值比(95%CI)0.75(0.43;1.28)]、血管浸润[比值比(95%CI)0.17(0.01;0.87)]。此外,在异时性原发性肿瘤患者中更频繁地发现多个肿瘤[比值比(95%CI)1.92(1.0;3.62)]。总之,暴露于切尔诺贝利辐射并发展为甲状腺乳头状癌和第二原发性恶性肿瘤的患者的甲状腺癌具有较少的生物学侵袭性病理特征。因此,这些患者术后接受放射性碘治疗的频率较低。因此,131I 照射对第二原发性肿瘤的发展可能没有明显影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验